Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Will Use Stratagene s QPCR Platform to Develop Instrument for IVD Market

NEW YORK, March 14 (GenomeWeb News) - Stratagene said today that Bayer Healthcare's diagnostics division will purchase minimally customized versions of Stratagene's Mx3005P QPCR instrument for use in a new platform Bayer is developing for molecular diagnostic tests.


As reported last week in BioCommerce Week, a GenomeWeb News sister publication, Stratagene will develop customized software and system features for the Mx3005P instrument for Bayer, and will receive milestone payments based upon its completion of this customization and regulatory activities needed to meet Bayer's clinical requirements.


Bayer will use the instruments as components in its modular quantitative PCR systems, which will expand Bayer's product portfolio in the in vitro diagnostic market, the companies said.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.